Lu 38-012
Lu 38-012 is a potent and selective dopamine D 4 receptor antagonist which has been used in scientific research.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Lu 38-012 is a potent and selective dopamine D 4 receptor antagonist which has been used in scientific research. It has an affinity (K i ) for the dopamine D 4.2 receptor of 7.5 nM and showed 16-fold selectivity for this receptor over the dopamine D 2S receptor (K i = 120 nM). The drug had relatively little affinity for other dopamine receptors.
Affinities at other targets have also been reported. The drug produces hypolocomotion and reverses dextroamphetamine- and phencyclidine (PCP)-induced hyperlocomotion without producing catalepsy in rodents. Lu 38-012 partially substituted for clozapine in drug discrimination tests in rodents.
It was developed by Lundbeck and was first described in the scientific literature by 2006.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1363150386 under CC BY-SA 4.0; modifications have been made.